- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 536-43-6] Dycloninehydrochloride
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-B0364A |
| Brand: | MCE |
| CAS: | 536-43-6 |
Overview
| MDL | MFCD00035386 |
|---|---|
| Molecular Weight | 325.87 |
| Molecular Formula | C18H28ClNO2 |
| SMILES | O=C(C1=CC=C(OCCCC)C=C1)CCN2CCCCC2.Cl |
1 Publications Citing Use of MCE
Summary
Dyclonine (Dyclocaine) hydrochloride is an orally effective ALDH covalent inhibitor (crosses blood-brain barrier), with an IC 50 of 35 µM for ALDH2 and 76 µM for ALDH3A1 . Dyclonine hydrochloride has sensitizing activities for targeted cancer cells and antibacterial. Dyclonine hydrochloride is also a local anesthetic that blocks the transmission of various nerve impulses or stimuli and inhibits the sensation of touch and pain [1] [2] [3] .
IC50 & Target
|
ALDH2 35 μM (IC 50 ) |
ALDH3 76 μM (IC 50 ) |
In Vitro
Dyclonine hydrochloride (50 µM; 24 h) sensitizes cancer cells to deficiency of cysteine and GSH
[1]
.
Dyclonine hydrochloride (0-2048 µg/mL; 24 or 48 h) shows significant bactericidal and fungicidal activity
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
| Cell Line: | HSC-4 cells |
| Concentration: | 50 µM |
| Incubation Time: | 24 h |
| Result: | Inhibited ALDH activity and induced 4-HNE accumulation in GSH-depleted cancer cells. |
Cell Viability Assay [2]
| Cell Line: | S. aureus , B. subtilis , E. coli , T. mentagrophyte |
| Concentration: | 0-2048 µg/mL |
| Incubation Time: | 24 h (for bacterial), 48 h (for fungi) |
| Result: | Showed good antibacterial and antifungal activity, with minimum microbicidal concentration of 0.006%, 0.025%, 0.012% and 0.025% for S. aureus , B. subtilis , E. coli , T. mentagrophyte , separately. |
In Vivo
Dyclonine hydrochloride (5 mg/kg; i.p.; single daily for 24 days) sensitizes the involucrin
+
differentiated tumor cells to sulfasalazine treatment in vivo
[1]
.
Dyclonine hydrochloride (5 mg/kg; i.p.; single daily for 21 days) suppress the growth of tumors formed by ALDH3A1-expressing gastric cancer stemlike cells when combines with sulfasalazine
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Athymic nude mice (HSC-2 cells implanted model) [1] . |
| Dosage: | 5 mg/kg |
| Administration: | Intraperitoneal injection; single daily for 24 days (combine with sulfasalazine). |
| Result: | Attenuated the formation of tumors by HSC-2 cells implanted in nude mice when combined with sulfasalazine. |
| Animal Model: | C57BL6 mice (K19-Wnt1/C2mE-KP cells implanted model) [1] . |
| Dosage: | 5 mg/kg |
| Administration: | Intraperitoneal injection; single daily for 21 days (combine with sulfasalazine). |
| Result: | Enhanced the antitumor effect of sulfasalazine on HNSCC tumors consisting of CD44vhigh stemlike tumor cells and involucrin + differentiated tumor cells. |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
H 2 O : 50 mg/mL ( 153.44 mM ; Need ultrasonic)
DMSO : ≥ 25 mg/mL ( 76.72 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 3.0687 mL | 15.3435 mL | 30.6871 mL |
| 5 mM | 0.6137 mL | 3.0687 mL | 6.1374 mL |
| 10 mM | 0.3069 mL | 1.5344 mL | 3.0687 mL |
References
- [1] Okazaki S, et al. Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells. Oncotarget. 2018 Sep 18;9(73):33832-33843.
- [2] FLORESTANO HJ, et al. Antimicrobial properties of dyclonine hydrochloride, a new topical anesthetic. J Am Pharm Assoc Am Pharm Assoc. 1956 May;45(5):320-5.
- [3] Khanna M, et al. Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases. J Biol Chem. 2011 Dec 16;286(50):43486-94.
Synonyms
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.